IDH1 and glioma: From the above results that TNFRSF1A expression was an independent prognostic indicator related to poor prognosis in gliomas, therefore, gliomas with IDH mutation or 1p/19q codeletion had a longer survival time, which was consistent with the conclusions of the previous studies.